Acceptable performance for the accuracy-based creatinine testing program
| Year-round | Specimen name | Creatinine | eGFR | ||||||
|---|---|---|---|---|---|---|---|---|---|
| CKD-EPI | MDRD 4 variable (IDMS-traceable) | ||||||||
| No. of participants | No. of acceptable performance (%) | No. of participants | No. of acceptable performance (%) | No. of participants | No. of acceptable performance (%) | ||||
| 2022-1st | CAC-22-01 | 1,687 | 1,339 (79.4) | 151 | 149 (98.7) | 460 | 445 (96.7) | ||
| CAC-22-02 | 1,687 | 1,497 (88.7) | 151 | 149 (98.7) | 460 | 457 (99.3) | |||
| CAC-22-03 | 1,687 | 1,582 (93.8) | 151 | 146 (96.7) | 460 | 450 (97.8) | |||
| 2022-2nd | CAC-22-04 | 1,706 | 1,520 (89.1) | 163 | 161 (98.8) | 461 | 458 (99.3) | ||
| CAC-22-05 | 1,706 | 1,610 (94.4) | 163 | 159 (97.5) | 461 | 450 (97.6) | |||
| CAC-22-06 | 1,706 | 1,597 (93.6) | 163 | 161 (98.8) | 461 | 457 (99.1) | |||
Abbreviations: eGFR, estimated glomerular filtration rate; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; MDRD, Modification of Diet in Renal Disease; IDMS, Isotope-Dilution Mass Spectrometry.